Sign Up to like & get
recommendations!
0
Published in 2020 at "Neurobiology of Aging"
DOI: 10.1016/j.neurobiolaging.2019.12.019
Abstract: Amyloid and tau pathological accumulation should be considered for Alzheimer's disease (AD) definition and before subjects' enrollment in disease-modifying trials. Although age, APOEε4, and sex influence cerebrospinal fluid (CSF) biomarker levels, none of these variables…
read more here.
Keywords:
status;
mci due;
alzheimer disease;
csf ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Brain Sciences"
DOI: 10.3390/brainsci13020244
Abstract: The early identification of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD), in an early stage of AD can expand the AD warning window. We propose a new capability index evaluating the spatial execution…
read more here.
Keywords:
mci due;
due alzheimer;
mild cognitive;
alzheimer disease ... See more keywords